JP2011528031A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011528031A5 JP2011528031A5 JP2011518059A JP2011518059A JP2011528031A5 JP 2011528031 A5 JP2011528031 A5 JP 2011528031A5 JP 2011518059 A JP2011518059 A JP 2011518059A JP 2011518059 A JP2011518059 A JP 2011518059A JP 2011528031 A5 JP2011528031 A5 JP 2011528031A5
- Authority
- JP
- Japan
- Prior art keywords
- substrate
- composition according
- pharmaceutically active
- substrate composition
- active substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims description 26
- 239000000758 substrate Substances 0.000 claims description 21
- 150000002632 lipids Chemical class 0.000 claims description 15
- 150000003904 phospholipids Chemical class 0.000 claims description 5
- 239000013543 active substance Substances 0.000 claims 9
- 239000011159 matrix material Substances 0.000 claims 6
- 230000000399 orthopedic effect Effects 0.000 claims 6
- 229920002988 biodegradable polymer Polymers 0.000 claims 4
- 239000004621 biodegradable polymer Substances 0.000 claims 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 4
- 239000011248 coating agent Substances 0.000 claims 4
- 238000000576 coating method Methods 0.000 claims 4
- 102000008186 Collagen Human genes 0.000 claims 3
- 108010035532 Collagen Proteins 0.000 claims 3
- 210000000988 bone and bone Anatomy 0.000 claims 3
- 229920001436 collagen Polymers 0.000 claims 3
- 239000003960 organic solvent Substances 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 229940078581 Bone resorption inhibitor Drugs 0.000 claims 2
- 229920000954 Polyglycolide Polymers 0.000 claims 2
- 229930182558 Sterol Natural products 0.000 claims 2
- 239000003242 anti bacterial agent Substances 0.000 claims 2
- 229940121375 antifungal agent Drugs 0.000 claims 2
- 239000002617 bone density conservation agent Substances 0.000 claims 2
- 235000012000 cholesterol Nutrition 0.000 claims 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 2
- 239000007943 implant Substances 0.000 claims 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims 2
- 229920000747 poly(lactic acid) Polymers 0.000 claims 2
- 239000004633 polyglycolic acid Substances 0.000 claims 2
- 239000004626 polylactic acid Substances 0.000 claims 2
- 150000003432 sterols Chemical class 0.000 claims 2
- 235000003702 sterols Nutrition 0.000 claims 2
- 238000013268 sustained release Methods 0.000 claims 2
- 239000012730 sustained-release form Substances 0.000 claims 2
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims 1
- XBBVURRQGJPTHH-UHFFFAOYSA-N 2-hydroxyacetic acid;2-hydroxypropanoic acid Chemical compound OCC(O)=O.CC(O)C(O)=O XBBVURRQGJPTHH-UHFFFAOYSA-N 0.000 claims 1
- 229910000684 Cobalt-chrome Inorganic materials 0.000 claims 1
- 102000009123 Fibrin Human genes 0.000 claims 1
- 108010073385 Fibrin Proteins 0.000 claims 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims 1
- 108010010803 Gelatin Proteins 0.000 claims 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims 1
- 229910001069 Ti alloy Inorganic materials 0.000 claims 1
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 claims 1
- WAIPAZQMEIHHTJ-UHFFFAOYSA-N [Cr].[Co] Chemical compound [Cr].[Co] WAIPAZQMEIHHTJ-UHFFFAOYSA-N 0.000 claims 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 239000003429 antifungal agent Substances 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 230000003416 augmentation Effects 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 claims 1
- 229920000229 biodegradable polyester Polymers 0.000 claims 1
- 239000004622 biodegradable polyester Substances 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 239000004568 cement Substances 0.000 claims 1
- 239000000919 ceramic Substances 0.000 claims 1
- 239000010952 cobalt-chrome Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 1
- 238000001704 evaporation Methods 0.000 claims 1
- 238000013265 extended release Methods 0.000 claims 1
- 150000004665 fatty acids Chemical group 0.000 claims 1
- 229950003499 fibrin Drugs 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- 235000021588 free fatty acids Nutrition 0.000 claims 1
- 229920000159 gelatin Polymers 0.000 claims 1
- 239000008273 gelatin Substances 0.000 claims 1
- 235000019322 gelatine Nutrition 0.000 claims 1
- 235000011852 gelatine desserts Nutrition 0.000 claims 1
- 229960002897 heparin Drugs 0.000 claims 1
- 229920000669 heparin Polymers 0.000 claims 1
- 239000008240 homogeneous mixture Substances 0.000 claims 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims 1
- 230000002163 immunogen Effects 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 229910052751 metal Inorganic materials 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 230000002188 osteogenic effect Effects 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims 1
- 201000001245 periodontitis Diseases 0.000 claims 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims 1
- 150000003905 phosphatidylinositols Chemical class 0.000 claims 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 150000003408 sphingolipids Chemical class 0.000 claims 1
- 239000010935 stainless steel Substances 0.000 claims 1
- 229910001220 stainless steel Inorganic materials 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 239000003356 suture material Substances 0.000 claims 1
- 229910052715 tantalum Inorganic materials 0.000 claims 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 claims 1
- 229960001295 tocopherol Drugs 0.000 claims 1
- 229930003799 tocopherol Natural products 0.000 claims 1
- 235000010384 tocopherol Nutrition 0.000 claims 1
- 239000011732 tocopherol Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 2
- 150000001982 diacylglycerols Chemical class 0.000 description 2
- 125000005265 dialkylamine group Chemical group 0.000 description 2
- 150000001985 dialkylglycerols Chemical class 0.000 description 2
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 2
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 150000008103 phosphatidic acids Chemical class 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8028908P | 2008-07-14 | 2008-07-14 | |
| US61/080,289 | 2008-07-14 | ||
| US15478509P | 2009-02-24 | 2009-02-24 | |
| US61/154,785 | 2009-02-24 | ||
| PCT/IL2009/000701 WO2010007623A1 (en) | 2008-07-14 | 2009-07-14 | Sustained-release drug carrier composition |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015002177A Division JP2015129128A (ja) | 2008-07-14 | 2015-01-08 | 徐放性薬剤キャリア組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011528031A JP2011528031A (ja) | 2011-11-10 |
| JP2011528031A5 true JP2011528031A5 (enExample) | 2012-08-23 |
| JP5681626B2 JP5681626B2 (ja) | 2015-03-11 |
Family
ID=41550058
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011518059A Active JP5681626B2 (ja) | 2008-07-14 | 2009-07-14 | 徐放性薬剤キャリア組成物 |
| JP2015002177A Ceased JP2015129128A (ja) | 2008-07-14 | 2015-01-08 | 徐放性薬剤キャリア組成物 |
| JP2016023906A Active JP6053083B2 (ja) | 2008-07-14 | 2016-02-10 | 徐放性薬剤キャリア組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015002177A Ceased JP2015129128A (ja) | 2008-07-14 | 2015-01-08 | 徐放性薬剤キャリア組成物 |
| JP2016023906A Active JP6053083B2 (ja) | 2008-07-14 | 2016-02-10 | 徐放性薬剤キャリア組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (6) | US8877242B2 (enExample) |
| EP (1) | EP2299953B1 (enExample) |
| JP (3) | JP5681626B2 (enExample) |
| CN (2) | CN102159163B (enExample) |
| AU (1) | AU2009272280B2 (enExample) |
| CA (1) | CA2730340C (enExample) |
| DK (1) | DK2299953T3 (enExample) |
| ES (1) | ES2630805T3 (enExample) |
| PL (1) | PL2299953T3 (enExample) |
| WO (1) | WO2010007623A1 (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010272167B2 (en) | 2009-07-14 | 2016-11-17 | Polypid Ltd. | Sustained-release drug carrier composition |
| JP5860409B2 (ja) | 2010-01-19 | 2016-02-16 | ポリピッド リミテッド | 徐放性核酸マトリックス組成物 |
| US9119793B1 (en) | 2011-06-28 | 2015-09-01 | Medicis Pharmaceutical Corporation | Gastroretentive dosage forms for doxycycline |
| CN103717206A (zh) * | 2011-07-27 | 2014-04-09 | 波利皮得有限公司 | 用于肽分子和多肽分子的受控释放的基质组合物 |
| CN102362861B (zh) * | 2011-11-04 | 2014-03-26 | 无锡中科光远生物材料有限公司 | 一种空心核壳结构复合纳米粒子及其制备方法 |
| US20130288951A1 (en) * | 2012-04-27 | 2013-10-31 | Biomet Manufacturing Corp. | Compositions and methods for coating implant surfaces to inhibit surgical infections |
| WO2013171382A1 (en) * | 2012-05-18 | 2013-11-21 | Oy Filana Ltd | Docetaxel-based prolonged-release cancer treatment drug |
| EA027543B1 (ru) * | 2012-08-02 | 2017-08-31 | Полипид Лтд. | Композиции и способы для лечения участков отсутствующей костной ткани и открытых переломов |
| US10842802B2 (en) | 2013-03-15 | 2020-11-24 | Medicis Pharmaceutical Corporation | Controlled release pharmaceutical dosage forms |
| WO2015069870A1 (en) * | 2013-11-07 | 2015-05-14 | The University Of North Carolina At Chapel Hill | Particles containing phospholipids or bioactive fatty acid |
| WO2015114633A1 (en) | 2014-01-30 | 2015-08-06 | Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. | Actin binding peptides and compositions comprising same for inhibiting angiogenes is and treating medical conditions associated with same |
| EP4299058A3 (en) | 2014-06-24 | 2024-03-27 | The Trustees of Princeton University | Process for encapsulating soluble biologics, therapeutics, and imaging agents |
| WO2016020901A1 (en) | 2014-08-07 | 2016-02-11 | Acerta Pharma B.V. | Methods of treating cancers, immune and autoimmune diseases, and inflammatory diseases based on btk occupancy and btk resynthesis rate |
| JP2017531461A (ja) * | 2014-10-02 | 2017-10-26 | ポリピッド リミテッド | インプラント周囲炎の治療法 |
| CN106999356A (zh) | 2014-10-02 | 2017-08-01 | 波利皮得有限公司 | 用于治疗和预防手术部位感染的组合物和方法 |
| US10695168B2 (en) * | 2015-04-17 | 2020-06-30 | Massachusetts Eye And Ear Infirmary | Prosthetic devices for semicircular canal defects |
| KR101773287B1 (ko) * | 2016-03-10 | 2017-08-31 | 고려대학교 산학협력단 | 골수염 치료 장치 |
| US11617896B2 (en) | 2015-07-10 | 2023-04-04 | Korea University Research And Business Foundation | Medical wound healing accelerator and osteomyelitis treatment device |
| AU2016378743A1 (en) | 2015-12-22 | 2018-08-02 | The Trustees Of Princeton University | Process for encapsulating soluble biologics, therapeutics, and imaging agents |
| WO2018107243A1 (en) * | 2016-12-16 | 2018-06-21 | Field Orthopaedics Pty Ltd | A medical implant and a method of coating a medical implant |
| WO2019055539A1 (en) | 2017-09-12 | 2019-03-21 | Prudhomme Robert K | CELLULOSIC POLYMER NANOPARTICLES AND METHODS OF FORMING THE SAME |
| JP2021501753A (ja) | 2017-11-03 | 2021-01-21 | ザ・トラスティーズ・オブ・プリンストン・ユニバーシティＴｈｅ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｐｒｉｎｃｅｔｏｎ Ｕｎｉｖｅｒｓｉｔｙ | 徐放性ナノキャリア製剤を形成するための疎水性イオン対化およびフラッシュナノ沈殿 |
| US12186436B2 (en) | 2018-07-19 | 2025-01-07 | The Trustees Of Princeton University | Triblock copolymer stabilizers for the formation of nanoparticles encapsulating soluble biologics, therapeutics, and imaging agents |
| US11731099B2 (en) | 2018-07-20 | 2023-08-22 | The Trustees Of Princeton University | Method for controlling encapsulation efficiency and burst release of water soluble molecules from nanoparticles and microparticles produced by inverse flash nanoprecipitation |
| US20200147032A1 (en) | 2018-11-14 | 2020-05-14 | Robert K. Prud'homme | Dihydromyricetin hot melt extrusion formulations and methods for forming them |
| JP7395210B2 (ja) * | 2019-08-08 | 2023-12-11 | アヴィデンス セラピューティクス， インコーポレイテッド | ミクロスフェアに基づく注射用セレコキシブ製剤 |
| TWI754876B (zh) * | 2019-12-31 | 2022-02-11 | 財團法人工業技術研究院 | 含藥多層薄膜與其形成方法 |
| EP4262783A1 (en) * | 2020-12-21 | 2023-10-25 | Polypid Ltd. | Compositions and methods for the treatment of solid tumors |
| US20220296524A1 (en) | 2021-01-29 | 2022-09-22 | Tionlab Therapeutics | Initial burst release controlled depot composition and a method thereof |
| KR102442807B1 (ko) | 2021-01-29 | 2022-09-15 | 주식회사 티온랩테라퓨틱스 | 초기 방출 제어된 데포 조성물 및 이의 제조방법 |
| KR20230115591A (ko) | 2022-01-27 | 2023-08-03 | 주식회사 티온랩테라퓨틱스 | 초기 방출 제어된 지질 융합 데포 조성물 및 이의 제조방법 |
| KR20250110749A (ko) | 2024-01-12 | 2025-07-21 | 주식회사 티온랩테라퓨틱스 | 소르비탄 포화지방산을 포함하는 서방성 지질 전구 제제 및 이의 제조방법 |
| KR20250118174A (ko) | 2024-01-29 | 2025-08-05 | 주식회사 티온랩테라퓨틱스 | 세마글루타이드의 개선된 의료 요법 제공을 위한 비만 및 당뇨 치료용로써, 소수성 이온 페어링 겔레이션을 통한 초기 방출이 제어된 데포 조성물 및 이의 제조방법 |
Family Cites Families (81)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) * | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4522803A (en) * | 1983-02-04 | 1985-06-11 | The Liposome Company, Inc. | Stable plurilamellar vesicles, their preparation and use |
| US4882167A (en) * | 1983-05-31 | 1989-11-21 | Jang Choong Gook | Dry direct compression compositions for controlled release dosage forms |
| US4578384A (en) * | 1984-02-15 | 1986-03-25 | The United States Of America As Represented By The Secretary Of The Army | Polylactic-polyglycolic acids combined with an acidic phospholipid-lysozyme complex for healing osseous tissue |
| US4522863A (en) | 1984-06-21 | 1985-06-11 | Kimberly-Clark Corporation | Soft nonwoven laminate bonded by adhesive on reinforcing scrim |
| JPS6163613A (ja) | 1984-09-04 | 1986-04-01 | Mitsui Toatsu Chem Inc | 顆粒状に調整された徐放性製剤 |
| US5043166A (en) * | 1987-01-09 | 1991-08-27 | Hadasit Medical Research, Inc. | Liposome/anthraquinone drug composition and method |
| IL91664A (en) * | 1988-09-28 | 1993-05-13 | Yissum Res Dev Co | Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release |
| EP0502119B1 (en) | 1989-11-13 | 1996-01-31 | Scios Nova, Inc. | Lipospheres for controlled delivery of substances |
| US6120805A (en) * | 1990-04-06 | 2000-09-19 | Rhone-Poulenc Rorer Sa | Microspheres, process for their preparation and their use |
| JPH046115A (ja) | 1990-04-25 | 1992-01-10 | Olympus Optical Co Ltd | 光学素子成形用型 |
| DK166600B1 (da) | 1991-01-17 | 1993-06-21 | Therkel Bisgaard | Vaerktoejssaet til brug ved suturering i dybe operationsaabninger eller legemshulrum |
| US5922340A (en) * | 1992-09-10 | 1999-07-13 | Children's Medical Center Corporation | High load formulations and methods for providing prolonged local anesthesia |
| US6180134B1 (en) * | 1993-03-23 | 2001-01-30 | Sequus Pharmaceuticals, Inc. | Enhanced ciruclation effector composition and method |
| CA2190121A1 (en) | 1994-03-15 | 1995-09-21 | Edith Mathiowitz | Polymeric gene delivery system |
| US6156337A (en) * | 1994-07-08 | 2000-12-05 | Opperbas Holding B.V. | Method for high loading of vesicles with biopolymeric substances |
| US6333021B1 (en) * | 1994-11-22 | 2001-12-25 | Bracco Research S.A. | Microcapsules, method of making and their use |
| US6040295A (en) | 1995-01-13 | 2000-03-21 | Genemedicine, Inc. | Formulated nucleic acid compositions and methods of administering the same for gene therapy |
| US5919480A (en) * | 1996-06-24 | 1999-07-06 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Liposomal influenza vaccine composition and method |
| JPH108035A (ja) | 1996-06-25 | 1998-01-13 | Akebono Brake Ind Co Ltd | 非石綿系摩擦材 |
| US5837221A (en) * | 1996-07-29 | 1998-11-17 | Acusphere, Inc. | Polymer-lipid microencapsulated gases for use as imaging agents |
| AU3981097A (en) | 1996-08-21 | 1998-03-06 | Alkermes Controlled Therapeutics, Inc. | Controlled release microparticles with a hydrophobic material |
| AU736056B2 (en) * | 1996-09-11 | 2001-07-26 | Imarx Pharmaceutical Corp. | Improved methods for diagnostic imaging using a contrast agent and a vasodilator |
| US6048551A (en) * | 1997-03-27 | 2000-04-11 | Hilfinger; John M. | Microsphere encapsulation of gene transfer vectors |
| JP2000511941A (ja) * | 1997-07-02 | 2000-09-12 | ユーロ−セルティーク エス．エイ． | 関節間隙および身体間隙における持効性麻酔 |
| US6287587B2 (en) | 1997-07-15 | 2001-09-11 | Takeda Chemical Industries, Ltd. | Process for producing sustained-release preparation by in-water drying |
| US6787132B1 (en) * | 1997-12-04 | 2004-09-07 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Combined chemo-immunotherapy with liposomal drugs and cytokines |
| PT1079805E (pt) | 1998-04-27 | 2005-03-31 | Opperbas Holding Bv | Composicao farmaceutica compreendendo factor viii e lipossomas neutros |
| US6423345B2 (en) * | 1998-04-30 | 2002-07-23 | Acusphere, Inc. | Matrices formed of polymer and hydrophobic compounds for use in drug delivery |
| EP1098610B1 (en) * | 1998-07-17 | 2009-04-15 | Pacira Pharmaceuticals, Inc. | Biodegradable compositions for the controlled release of encapsulated substances |
| US6162462A (en) * | 1998-08-12 | 2000-12-19 | New York University | Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient |
| US6153217A (en) * | 1999-01-22 | 2000-11-28 | Biodelivery Sciences, Inc. | Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents |
| US6083482A (en) * | 1999-05-11 | 2000-07-04 | Icn Pharmaceuticals, Inc. | Conformationally locked nucleosides and oligonucleotides |
| AU5624500A (en) | 1999-06-18 | 2001-01-09 | Collaborative Group, Ltd., The | Hyaluronic acid microspheres for sustained gene transfer |
| DE10001172A1 (de) * | 2000-01-13 | 2001-07-26 | Max Planck Gesellschaft | Templatieren von Feststoffpartikeln mit Polymermultischichten |
| US6267587B1 (en) * | 2000-07-06 | 2001-07-31 | Johnson & Johnson Vision Care, Inc. | Thermal curing oven and thermal curing process |
| US6967028B2 (en) * | 2000-07-31 | 2005-11-22 | Mainelab | Prolonged release microspheres for injectable administration |
| AU2001296494A1 (en) * | 2000-10-02 | 2002-04-15 | Arizeke Pharmaceuticals, Inc. | Compositions and methods for the transport of biologically active agents across cellular barriers |
| US7749539B2 (en) * | 2000-11-30 | 2010-07-06 | Efrat Biopolymers Ltd. | Polymeric formulations for drug delivery |
| FI20010540A0 (fi) * | 2001-03-16 | 2001-03-16 | Yli Urpo Antti | Komposiitti pehmyt- ja kovakudosvammojen korjaamiseksi ja mainitun komposiitin käyttö |
| JP2005509604A (ja) * | 2001-09-28 | 2005-04-14 | マクニール−ピーピーシー・インコーポレイテッド | 菓子組成物を含む剤形 |
| TWI226249B (en) * | 2001-12-19 | 2005-01-11 | Ind Tech Res Inst | Biodegradable composite matrix for enhancing angiogenesis |
| AU2003215388A1 (en) * | 2002-02-22 | 2003-09-09 | Purdue Research Foundation | Magnetic nanomaterials and methods for detection of biological materials |
| EP1509203B1 (en) * | 2002-05-15 | 2016-04-13 | California Pacific Medical Center | Delivery of nucleic acid-like compounds |
| US7144430B2 (en) * | 2002-07-12 | 2006-12-05 | Motion Control, Inc. | Wrist device for use with a prosthetic limb |
| SE0202619D0 (sv) * | 2002-09-05 | 2002-09-05 | Fredrik Nederberg | New Polymers and Applications |
| EP1601326A4 (en) * | 2003-02-12 | 2011-05-11 | Ceremed Inc | RANDOM ALKYLENE OXIDE COPOLYMERS FOR MEDICAL AND SURGICAL USES |
| GB0305941D0 (en) * | 2003-03-14 | 2003-04-23 | Camurus Ab | Composition |
| AU2004228849B2 (en) * | 2003-04-10 | 2010-05-06 | Teijin Limited | Biodegradable film having honeycomb structure |
| US20040247624A1 (en) * | 2003-06-05 | 2004-12-09 | Unger Evan Charles | Methods of making pharmaceutical formulations for the delivery of drugs having low aqueous solubility |
| US20060188573A1 (en) * | 2003-06-10 | 2006-08-24 | Anna Imberg | Composite materials and particles |
| US20050249697A1 (en) * | 2003-09-24 | 2005-11-10 | Uhrich Kathryn E | Compositions and methods for the inhibition of bone growth and resorption |
| JP2005154514A (ja) * | 2003-11-21 | 2005-06-16 | Univ Waseda | 機能性生分解性材料およびその製造方法 |
| JP4647497B2 (ja) * | 2003-11-21 | 2011-03-09 | 帝人株式会社 | 組織再生用基材および細胞との複合体とその製造方法 |
| CA2553426A1 (en) * | 2004-01-15 | 2005-08-04 | Alza Corporation | Liposome composition for delivery of therapeutic agents |
| US8277831B2 (en) * | 2004-02-17 | 2012-10-02 | Advanced Technologies And Regenerative Medicine, Llc. | Drug-enhanced adhesion prevention |
| US7744644B2 (en) * | 2004-03-19 | 2010-06-29 | Boston Scientific Scimed, Inc. | Medical articles having regions with polyelectrolyte multilayer coatings for regulating drug release |
| MXPA06014095A (es) * | 2004-06-04 | 2007-08-07 | Camurus Ab | Formulaciones de deposito de lipidos. |
| EP1765367A4 (en) * | 2004-06-15 | 2010-08-11 | Therapeutics Inc Encore | PHOSPHOLIPID COMPOSITIONS AND METHOD FOR THEIR PREPARATION AND USE |
| WO2006009825A1 (en) * | 2004-06-17 | 2006-01-26 | Virun, Inc. | Compositions comprising a mucoadhesive protein and an active principle for mucosal delivery of said agents |
| KR20070054644A (ko) * | 2004-07-26 | 2007-05-29 | 액테리온 파마슈티칼 리미티드 | 미립자 제형으로 흡입된 일로프로스트에 의한 폐고혈압의치료 |
| US20080095849A1 (en) * | 2005-04-25 | 2008-04-24 | Amgen Inc. | Peptide sustained release compositions and uses thereof |
| US20070141134A1 (en) * | 2005-12-16 | 2007-06-21 | Kosak Matthew K | Shielded micelles for polynucleotide delivery |
| EP1976460A4 (en) * | 2006-01-19 | 2012-06-20 | Warsaw Orthopedic Inc | INJECTABLE AND FORMABLE BONE REPLACEMENT MATERIALS |
| US20090318355A1 (en) * | 2006-02-15 | 2009-12-24 | Chen Thomas T | Compositions and methods for promoting tissue repair and wound healing |
| CA2648099C (en) * | 2006-03-31 | 2012-05-29 | The Brigham And Women's Hospital, Inc | System for targeted delivery of therapeutic agents |
| US8703167B2 (en) * | 2006-06-05 | 2014-04-22 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug |
| WO2008108286A1 (ja) | 2007-03-02 | 2008-09-12 | Teika Pharmaceutical Co., Ltd. | 経皮吸収医薬組成物、医薬組成物貯蔵ユニットおよびこれを利用する経皮吸収製剤 |
| WO2008124634A1 (en) * | 2007-04-04 | 2008-10-16 | Massachusetts Institute Of Technology | Polymer-encapsulated reverse micelles |
| US20090006311A1 (en) * | 2007-06-28 | 2009-01-01 | Yahoo! Inc. | Automated system to improve search engine optimization on web pages |
| WO2009006311A2 (en) | 2007-06-29 | 2009-01-08 | Wisconsin Alumni Research Foundation | Structuring effect of cholesterol in peg-phospholipid micelles, drug delivery of amphotericin b, and combination antifungals |
| US20090110713A1 (en) | 2007-10-31 | 2009-04-30 | Florencia Lim | Biodegradable polymeric materials providing controlled release of hydrophobic drugs from implantable devices |
| WO2009061515A1 (en) | 2007-11-09 | 2009-05-14 | Northeastern University | Self-assembling micelle-like nanoparticles for systemic gene delivery |
| WO2009110939A2 (en) | 2007-12-10 | 2009-09-11 | Massachusetts Institute Of Technology | Drug delivery system for pharmaceuticals and radiation |
| TWI373474B (en) | 2007-12-31 | 2012-10-01 | Univ Kaohsiung Medical | Stem cell transfection method |
| US8685432B2 (en) * | 2008-03-25 | 2014-04-01 | University Of Utah Research Foundation | Controlled release tissue graft combination biomaterials |
| US8128983B2 (en) * | 2008-04-11 | 2012-03-06 | Abbott Cardiovascular Systems Inc. | Coating comprising poly(ethylene glycol)-poly(lactide-glycolide-caprolactone) interpenetrating network |
| PL2279254T3 (pl) | 2008-04-15 | 2017-11-30 | Protiva Biotherapeutics Inc. | Nowe preparaty lipidowe do dostarczania kwasów nukleinowych |
| AU2010272167B2 (en) | 2009-07-14 | 2016-11-17 | Polypid Ltd. | Sustained-release drug carrier composition |
| KR101114771B1 (ko) | 2009-09-23 | 2012-03-05 | 유영환 | 석쇠 |
| JP5860409B2 (ja) | 2010-01-19 | 2016-02-16 | ポリピッド リミテッド | 徐放性核酸マトリックス組成物 |
-
2009
- 2009-07-14 AU AU2009272280A patent/AU2009272280B2/en active Active
- 2009-07-14 CN CN200980133937.3A patent/CN102159163B/zh active Active
- 2009-07-14 JP JP2011518059A patent/JP5681626B2/ja active Active
- 2009-07-14 EP EP09797631.0A patent/EP2299953B1/en active Active
- 2009-07-14 WO PCT/IL2009/000701 patent/WO2010007623A1/en not_active Ceased
- 2009-07-14 ES ES09797631.0T patent/ES2630805T3/es active Active
- 2009-07-14 US US13/003,955 patent/US8877242B2/en active Active
- 2009-07-14 DK DK09797631.0T patent/DK2299953T3/en active
- 2009-07-14 CA CA2730340A patent/CA2730340C/en active Active
- 2009-07-14 PL PL09797631T patent/PL2299953T3/pl unknown
- 2009-07-14 CN CN201410412237.0A patent/CN104274866B/zh active Active
-
2014
- 2014-10-26 US US14/523,894 patent/US9421271B2/en active Active
- 2014-10-26 US US14/523,893 patent/US20150071981A1/en not_active Abandoned
-
2015
- 2015-01-08 JP JP2015002177A patent/JP2015129128A/ja not_active Ceased
-
2016
- 2016-02-10 JP JP2016023906A patent/JP6053083B2/ja active Active
- 2016-08-23 US US15/244,048 patent/US10105443B2/en active Active
-
2018
- 2018-09-06 US US16/122,986 patent/US10682412B2/en active Active
-
2020
- 2020-06-02 US US16/889,826 patent/US20200289651A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011528031A5 (enExample) | ||
| JP2012533334A5 (enExample) | ||
| JP5681626B2 (ja) | 徐放性薬剤キャリア組成物 | |
| JP5738856B2 (ja) | 徐放性薬物担体組成物 | |
| JP2021063123A (ja) | 手術部位感染の処置および予防のための組成物および方法 | |
| JP2014521636A5 (enExample) | ||
| Jagoda | Polyhydroxyalkanoate-based thin films: characterization and optimization for calcium phosphate crystallization | |
| HK1161069A (en) | Sustained-release drug carrier composition | |
| EA041251B1 (ru) | Применение фармацевтической композиции для лечения или профилактики инфекций области разреза при хирургическом вмешательстве |